PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Jason K Kim Selected Research
Insulin Resistance
12/2007
Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
09/2005
Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver.
07/2005
Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.
06/2005
Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle.
06/2005
Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance.
07/2004
Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
06/2004
Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.
03/2004
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle.
08/2003
Insulin resistance in tetracycline-repressible Munc18c transgenic mice.
06/2003
Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice.
Articles by Research Topic
Disease
10
Insulin Resistance
12/2007 - 06/2003
1
Aneurysm (Aneurysms)
09/2008
1
Inflammation
10/2007
1
Hypersensitivity (Allergy)
03/2007
1
Glucose Intolerance
09/2006
1
Obesity
07/2006
1
Hypertension (High Blood Pressure)
07/2004
Drug/Important Bio-Agent (IBA)
4
Insulin (Novolin)
FDA Link
12/2007 - 06/2004
2
Phosphotransferases (Kinase)
IBA
03/2007 - 07/2006
1
Glucose (Dextrose)
FDA Link
Generic
10/2007
1
CD66 antigens
IBA
09/2006
1
PPAR alpha
IBA
09/2005
1
Sterol Esterase (Hormone-Sensitive Lipase)
IBA
07/2005
1
Acyl Coenzyme A (Acyl CoA)
IBA
06/2005
1
Caveolin 3
IBA
06/2005
1
Insulin Receptor
IBA
06/2005
1
PPAR gamma
IBA
07/2004
1
Antigens
IBA
06/2004
1
Non-Receptor Type 1 Protein Tyrosine Phosphatase
IBA
06/2004
1
Fatty Acid Transport Proteins (Fatty Acid Transport Protein)
IBA
03/2004
1
Tetracycline (Achromycin)
FDA Link
Generic
08/2003
1
rosiglitazone (Avandia)
FDA Link
06/2003
Therapy/Procedure
1
Stents
09/2008